AHA 2023 Treatment Strategies for Cardiomyopathy in Children
Diagnosis and management considerations in paediatric cardiomyopathy. AHA 2023 Treatment Strategies for Cardiomyopathy in Children
2024 International Society for Heart and Lung Transplantation Guidelines for the Evaluation and Care of Cardiac Transplant Candidates
2024 International Society for Heart and Lung Transplantation Guidelines for the Evaluation and Care of Cardiac Transplant Candidates
EMQN: Recommendations for genetic testing in inherited cardiomyopathies and arrhythmias
2023 framework for genetic counselling and testing in inherited cardiovascular diseases. EMQN: Recommendations for genetic testing in inherited cardiomyopathies and arrhythmias
Heart Foundation of Australia: Additional resources to support patients with heart failure
Heart Foundation of Australia: Additional resources to support patients with heart failure Developed based on the Guidelines for the prevention, detection, and management of heart failure in Australia (the Guidelines), tools and resources to support provision of best practice care for patients with heart failure
Heart Foundation of Australia / Cardiac Society of Australia and New Zealand (CSANZ) Clinical Guidelines for the Diagnosis and Management of Heart Failure (2018)
Nationally endorsed guideline aligning with Australian practice, referral pathways, and available therapies. Heart Foundation of Australia / Cardiac Society of Australia and New Zealand (CSANZ) Clinical Guidelines for the Diagnosis and Management of Heart Failure (2018)
ESC 2021 Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
European counterpart addressing diagnostic algorithms, imaging, comorbidities, and management of heart failure with reduced and preserved ejection fraction. ESC 2021 Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
ACC / AHA / HFSA 2022 Guideline for the Management of Heart Failure
Comprehensive guidance on diagnosis, classification, and management of heart failure, including updated pharmacological therapy (ARNI, SGLT2 inhibitors), devices, and advanced care. ACC / AHA / HFSA 2022 Guideline for the Management of Heart Failure
ESC Peripartum Cardiomyopathy Position Statement (2020)
Diagnosis, management, and counselling for future pregnancies. ESC Peripartum Cardiomyopathy Position Statement (2020)
AHA / ACC 2024 Guideline for the Management of Hypertrophic Cardiomyopathy
Updates the 2020 guideline with revised diagnostic criteria, risk stratification, and management including new pharmacological therapies and genetic counselling guidance. AHA / ACC 2024 Guideline for the Management of Hypertrophic Cardiomyopathy
Australia–New Zealand Expert Consensus Statement on Cardiac Amyloidosis (2024)
Regionally tailored recommendations on investigation, diagnosis, and management of cardiac amyloidosis, incorporating local service structures and therapy access. Australia–New Zealand Expert Consensus Statement on Cardiac Amyloidosis (2024)